← Browse by Condition
Medical Condition
irritable bowel syndrome
Total Trials
10
Recruiting Now
10
Trial Phases
Phase 2, Phase 3
ClinicalMetric tracks all active clinical trials for irritable bowel syndrome sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.
Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.
Frequently Asked Questions — irritable bowel syndrome Clinical Trials
How many clinical trials are currently recruiting for irritable bowel syndrome?
ClinicalMetric currently tracks 10 actively recruiting clinical trials for irritable bowel syndrome, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 10. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for irritable bowel syndrome?
irritable bowel syndrome research spans Phase 2 (3 trials), Phase 3 (1 trial). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a irritable bowel syndrome clinical trial?
Eligibility criteria for irritable bowel syndrome trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Trial Phases
Phase 2 3
Phase 3 1
Top Sponsors
1 trial
1 trial
1 trial
1 trial
1 trial
Recruiting Clinical Trials
NCT07581756
Recruiting
Enrollment
46 pts
Location
China
Sponsor
The First Affiliated Hospital ...
NCT05525598
Recruiting
Enrollment
166 pts
Location
Denmark
Sponsor
University of Aarhus
NCT07545772 Phase 2
Recruiting
Enrollment
342 pts
Location
United States, Belgi...
Sponsor
Eli Lilly and Company
NCT05776914 Phase 2
Recruiting
Enrollment
43 pts
Location
United States
Sponsor
Madhusudan (Madhu) Grover, MBB...
NCT06866106
Recruiting
Enrollment
50 pts
Location
United States
Sponsor
Massachusetts General Hospital
NCT06473454
Recruiting
Enrollment
72 pts
Location
Turkey (Türkiye)
Sponsor
Istanbul Saglik Bilimleri Univ...
NCT04918329
Recruiting
Enrollment
2,000 pts
Location
France
Sponsor
University Hospital, Rouen
NCT04974593 Phase 3
Recruiting
Enrollment
90 pts
Location
Belgium
Sponsor
Universitair Ziekenhuis Brusse...
NCT05808036
Recruiting
Enrollment
110 pts
Location
Belgium
Sponsor
Universitaire Ziekenhuizen KU ...
NCT03339128 Phase 2
Recruiting
Enrollment
95 pts
Location
United States, Bulga...
Sponsor
AbbVie
Related Conditions
irritable bowel syndrome with diarrhea ibs d (1) repetitive transcranial magnetic stimulation rtms (1) chronic diarrhea (1) intestinal flora (1) bodily distress disorder moderate (1) bodily distress disorder severe (1) fibromyalgia (1) chronic fatigue syndrome (1) somatization (1) constipation (1) diarrhea (1) dyspepsia (1)
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: September 2026 · Data Methodology